Compare EVO & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | MG |
|---|---|---|
| Founded | 1993 | 1978 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.6M | 531.0M |
| IPO Year | 2007 | 2008 |
| Metric | EVO | MG |
|---|---|---|
| Price | $1.53 | $21.26 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.23 | N/A |
| AVG Volume (30 Days) | 83.4K | ★ 271.9K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $700,970,000.00 |
| Revenue This Year | N/A | $3.18 |
| Revenue Next Year | $20.47 | $5.37 |
| P/E Ratio | ★ N/A | $71.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $9.45 |
| 52 Week High | $4.19 | $21.92 |
| Indicator | EVO | MG |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 57.56 |
| Support Level | $1.50 | $20.36 |
| Resistance Level | $1.97 | $21.85 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 60.73 | 53.57 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.